| 0 |
ORAL MUCOSAL SCAR |
1 |
0.0455 |
| 1 |
NASAL MUCOSAL BLISTERING |
1 |
0.0185 |
| 2 |
WOUND COMPLICATION |
43 |
0.0125 |
| 3 |
PRODUCT PRIMARY PACKAGING ISSUE |
1 |
0.0089 |
| 4 |
WOUND INFECTION FUNGAL |
1 |
0.0082 |
| 5 |
WOUND INFECTION PSEUDOMONAS |
2 |
0.0064 |
| 6 |
WOUND DECOMPOSITION |
1 |
0.0060 |
| 7 |
ANORECTAL SWELLING |
1 |
0.0044 |
| 8 |
WOUND SECRETION |
15 |
0.0038 |
| 9 |
PATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0037 |
| 10 |
EXCESSIVE GRANULATION TISSUE |
3 |
0.0037 |
| 11 |
PRODUCT ADMINISTRATION INTERRUPTED |
24 |
0.0031 |
| 12 |
SALIVARY GLAND CALCULUS |
1 |
0.0027 |
| 13 |
POOR PERSONAL HYGIENE |
1 |
0.0019 |
| 14 |
WOUND DEHISCENCE |
6 |
0.0018 |
| 15 |
WOUND |
41 |
0.0015 |
| 16 |
TRACHEOSTOMY |
2 |
0.0014 |
| 17 |
WOUND HAEMORRHAGE |
5 |
0.0014 |
| 18 |
PRODUCT RESIDUE PRESENT |
7 |
0.0013 |
| 19 |
WOUND INFECTION |
14 |
0.0013 |
| 20 |
SUPERINFECTION BACTERIAL |
1 |
0.0013 |
| 21 |
SYSTEMIC INFECTION |
2 |
0.0012 |
| 22 |
SYNDACTYLY |
1 |
0.0012 |
| 23 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 24 |
SKIN FRAGILITY |
2 |
0.0008 |
| 25 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
4 |
0.0007 |
| 26 |
OESOPHAGEAL STENOSIS |
2 |
0.0007 |
| 27 |
SKIN WOUND |
1 |
0.0006 |
| 28 |
WOUND INFECTION STAPHYLOCOCCAL |
1 |
0.0006 |
| 29 |
APPLICATION SITE DISCOMFORT |
1 |
0.0006 |
| 30 |
SKIN INFECTION |
6 |
0.0005 |
| 31 |
RADIOTHERAPY |
1 |
0.0005 |
| 32 |
PRODUCT COMPLAINT |
13 |
0.0005 |
| 33 |
UNDERWEIGHT |
1 |
0.0005 |
| 34 |
APPLICATION SITE PRURITUS |
9 |
0.0004 |
| 35 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 36 |
IMPAIRED HEALING |
12 |
0.0004 |
| 37 |
TREATMENT NONCOMPLIANCE |
18 |
0.0003 |
| 38 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
2 |
0.0003 |
| 39 |
BLISTER |
17 |
0.0003 |
| 40 |
APPLICATION SITE DRYNESS |
1 |
0.0003 |
| 41 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 42 |
DRUG EFFECT LESS THAN EXPECTED |
4 |
0.0003 |
| 43 |
SCAB |
3 |
0.0003 |
| 44 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 45 |
APPLICATION SITE DISCOLOURATION |
1 |
0.0002 |
| 46 |
ONYCHOMADESIS |
1 |
0.0002 |
| 47 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 48 |
EYE OPERATION |
1 |
0.0002 |
| 49 |
SKIN ABRASION |
1 |
0.0002 |
| 50 |
PRODUCT USE ISSUE |
38 |
0.0002 |
| 51 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 52 |
INSURANCE ISSUE |
3 |
0.0002 |
| 53 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 54 |
SCRATCH |
2 |
0.0002 |
| 55 |
JOINT DISLOCATION |
2 |
0.0002 |
| 56 |
NORMAL NEWBORN |
1 |
0.0002 |
| 57 |
HYPERKERATOSIS |
1 |
0.0002 |
| 58 |
ILL-DEFINED DISORDER |
11 |
0.0002 |
| 59 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 60 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 61 |
PROCTALGIA |
1 |
0.0002 |
| 62 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 63 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 64 |
LIMB INJURY |
4 |
0.0001 |
| 65 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 66 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 67 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 68 |
ORAL DISORDER |
1 |
0.0001 |
| 69 |
PRODUCT DOSE OMISSION ISSUE |
40 |
0.0001 |
| 70 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
26 |
0.0001 |
| 71 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 72 |
FURUNCLE |
1 |
0.0001 |
| 73 |
LOCALISED INFECTION |
3 |
0.0001 |
| 74 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 75 |
PSYCHOMOTOR HYPERACTIVITY |
2 |
0.0001 |
| 76 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 77 |
APPENDICITIS |
1 |
0.0001 |
| 78 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 79 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 80 |
JOINT INJURY |
2 |
0.0001 |
| 81 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 82 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 83 |
SKIN DISORDER |
3 |
0.0001 |
| 84 |
PRODUCT QUALITY ISSUE |
12 |
0.0001 |
| 85 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 86 |
PRODUCT ADHESION ISSUE |
3 |
0.0001 |
| 87 |
ACCIDENT |
1 |
0.0001 |
| 88 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 89 |
BEDRIDDEN |
1 |
0.0001 |
| 90 |
INFECTION |
11 |
0.0001 |
| 91 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 92 |
SKIN REACTION |
1 |
0.0001 |
| 93 |
SKIN IRRITATION |
3 |
0.0001 |
| 94 |
ULCER |
1 |
0.0001 |
| 95 |
SKIN EXFOLIATION |
5 |
0.0001 |
| 96 |
SCAR |
1 |
0.0001 |
| 97 |
ILLNESS |
6 |
0.0001 |
| 98 |
ARTHROPATHY |
3 |
0.0001 |
| 99 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 100 |
TASTE DISORDER |
1 |
0.0000 |
| 101 |
DERMATITIS |
1 |
0.0000 |
| 102 |
RASH PAPULAR |
1 |
0.0000 |
| 103 |
PRURITUS |
15 |
0.0000 |
| 104 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 105 |
PNEUMONITIS |
1 |
0.0000 |
| 106 |
DEMENTIA |
1 |
0.0000 |
| 107 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 108 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 109 |
DISCOMFORT |
2 |
0.0000 |
| 110 |
EPILEPSY |
1 |
0.0000 |
| 111 |
FUNGAL INFECTION |
1 |
0.0000 |
| 112 |
BURNING SENSATION |
2 |
0.0000 |
| 113 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 114 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 115 |
MOBILITY DECREASED |
2 |
0.0000 |
| 116 |
OFF LABEL USE |
24 |
0.0000 |
| 117 |
FALL |
9 |
0.0000 |
| 118 |
DIABETES MELLITUS |
2 |
0.0000 |
| 119 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 120 |
HYPERHIDROSIS |
3 |
0.0000 |
| 121 |
SEPTIC SHOCK |
1 |
0.0000 |
| 122 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 123 |
DRY SKIN |
3 |
0.0000 |
| 124 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 125 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 126 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 127 |
ECZEMA |
1 |
0.0000 |
| 128 |
SPEECH DISORDER |
1 |
0.0000 |
| 129 |
DRUG INEFFECTIVE |
25 |
0.0000 |
| 130 |
OEDEMA |
1 |
0.0000 |
| 131 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 132 |
BONE PAIN |
1 |
0.0000 |
| 133 |
SURGERY |
1 |
0.0000 |
| 134 |
INJURY |
1 |
0.0000 |
| 135 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 136 |
CARDIAC ARREST |
1 |
0.0000 |
| 137 |
DEATH |
10 |
0.0000 |
| 138 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 139 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 140 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 141 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 142 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 143 |
CARDIAC DISORDER |
1 |
0.0000 |
| 144 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 145 |
SINUSITIS |
1 |
0.0000 |
| 146 |
HAEMORRHAGE |
1 |
0.0000 |
| 147 |
MALAISE |
4 |
0.0000 |
| 148 |
PAIN |
4 |
0.0000 |
| 149 |
URTICARIA |
1 |
0.0000 |
| 150 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 151 |
COVID-19 |
1 |
0.0000 |
| 152 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 153 |
ANAEMIA |
1 |
0.0000 |
| 154 |
NAUSEA |
4 |
0.0000 |
| 155 |
ERYTHEMA |
1 |
0.0000 |
| 156 |
RASH |
2 |
0.0000 |
| 157 |
WEIGHT INCREASED |
1 |
0.0000 |
| 158 |
DEPRESSION |
1 |
0.0000 |
| 159 |
COUGH |
1 |
0.0000 |
| 160 |
ANXIETY |
1 |
0.0000 |
| 161 |
PNEUMONIA |
1 |
0.0000 |
| 162 |
PYREXIA |
1 |
0.0000 |
| 163 |
ASTHENIA |
1 |
0.0000 |
| 164 |
ARTHRALGIA |
1 |
0.0000 |